Personnel

Alan M. Solinger, MD, named clinical immunology VP by biopharmaceutical company

Published in Gene Therapy Weekly, August 25th, 2005

XOMA Ltd. (XOMA), a biopharmaceutical company developing antibody and protein-based drugs for cancer, immunological disorders and infectious diseases, announced the appointment of Alan M. Solinger, MD, as Vice president of clinical immunology.

Before joining XOMA, Solinger was director of clinical research at Amgen, Inc. where he participated in the design of the clinical and commercial strategies for marketed products Enbrel (Etanercept) and Kineret (Anakinra), and for other late-stage products. Prior to that he was medical director for Parexel International, Inc.

Solinger received his bachelor's degree in chemical biology from Columbia University...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2005-08-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry